(Q72323475)
Statements
Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group (English)
L X Cubeddu
K Pendergrass
T Ryan
M York
G Burton
M Meshad
D Galvin